Clinical Trial Update: Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing pharmacokinetics, pharmacodynamics, safety and tolerability of glycopyrronium bromide in children aged 6 to less than 12 with a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Glycopyrronium bromide (glycopyrronium bromide)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Asthma | Phase 2 | Status: RECRUITING